Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation
Clinical trial NCT01178216 · COMPLETED
Trial details
- NCT number
- NCT01178216
- Sponsor
- Stanley Jordan, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2017-07-28
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.